# A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

> **NCT00733798** · PHASE1,PHASE2 · TERMINATED · sponsor: **TransMolecular** · enrollment: 58 (estimated)

## Conditions studied

- Melanoma
- Malignant Melanoma
- Metastatic Melanoma

## Interventions

- **DRUG:** 131I-TM601

## Key facts

- **NCT ID:** NCT00733798
- **Lead sponsor:** TransMolecular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 58 (ESTIMATED)
- **Why stopped:** For Strategic Reasons
- **Last updated:** 2009-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733798, "A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00733798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*